Many women report cognitive difficulties — forgetfulness, distractibility, feeling foggy —during the transition to menopause. While much attention has been devoted to the treatment of vasomotor symptoms, such as hot flashes or night sweats, less attention has focused on the management of the memory difficulties and other cognitive problems many menopausal women may suffer.
According to new research presented at the annual meeting of the American psychiatric Association in May, the stimulant lisdexamfetamine (LDX) – marketed in the US as the ADHD medication Vyvanse – improved attention and concentration, organization, and memory in a group of post-menopausal women.
This was a small study, including only 30 subjects; however, the results are promising and suggest that stimulants may help many women who experience cognitive difficulties as they enter into the menopause.
Ruta Nonacs, MD PhD